# OnCo record keunchil-park (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/keunchil-park/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "keunchil-park" ;
  schema:name "Keunchil Park"@en ;
  schema:description "Korean lung cancer specialist who led CHRYSALIS, the first human study of amivantamab, whose exon 20 insertion cohort earned the drug its first approval."@en ;
  schema:url <https://onco.cc/people/keunchil-park/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "lung", "targeted-therapy", "trialist" ;
  schema:jobTitle "Medical oncologist and trial lead, Samsung Medical Center, Seoul" ;
  schema:sameAs <https://orcid.org/0000-0002-4846-7449> ;
  onco:cancers <https://onco.cc/cancers/egfr-mutant-nsclc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:institutions <https://onco.cc/institutions/samsung-medical-center/> ;
  onco:trials <https://onco.cc/trials/chrysalis/> ;
  schema:affiliation <https://onco.cc/institutions/samsung-medical-center/> .